Chih-Ning Lin Email & Phone Number

Essen, North Rhine-Westphalia, Germany

Düsseldorf, North Rhine-Westphalia, Germany

• Tested intangible assets (goodwill and trademarks) for impairment by using a valuation approach (DCF-WACC) and presented the results to team members• Cleared ad hoc questions from PwC Germany regarding the impairment test • Engaged in building a financial model facilitating steering based on changes in planning parameters• Supported finalizing the short-term and long-term business planning

Taipei, Taipei City, Taiwan

• Engaged in an Initial Public Offering (IPO) project of a Taiwanese company including auditing financials, communicating accounting and internal control issues with the company, examining regulatory documents, and resolving questions from the competent authority Taipei Exchange (TPEx) • Audited and reviewed financial statements of 24 listed/unlisted companies and overseas subsidiaries in China, the USA, and Germany; industries included manufacturing, biotechnology, telecommunications and hospitality • Cleared ad hoc enquiries from National Taxation Bureau, Taipei Exchange, and Taiwan Stock Exchange Corporation • Consulted client companies with regard to accounting issues, tax procedure, and tax returns • Managed a team of 2 to 4 auditors• Received superior performance rating in audit from managers

Taipei, Taipei City, Taiwan

Master'S Degree, Management

• Specialized in Finance • Master thesis evaluating the largest biopharma M&A deal in 2021 −Australia’s CSL acquires Swiss Vifor Pharma−.

Bachelor'S Degree, Business Administration In Accountancy, Gpa 3.4/4 (Equivalent German Grade 2.5)

Core coursework: Financial Statement Analysis, Advanced Accounting, Intermediate Accounting, Cost and Management Accounting, Accounting.